A subgroup analysis of patients with severe AIS located in the posterior circulation showed a trend toward better recovery with MLC601.
← all excerpts
Translational Medicine in Acute Ischemic Stroke and Traumatic Brain Injury-NeuroAiD Trials, from Traditional Beliefs to Evidence-Based Therapy.
2
—
—
The sentences
These results indicate that MLC601 may be more effective than piracetam in reducing visual field defects in HH patients, but this did not reach statistical significance due to the small sample size.